Viemed Healthcare, Inc. (VMD)
NASDAQ: VMD · Real-Time Price · USD
8.54
-0.07 (-0.81%)
At close: Nov 20, 2024, 4:00 PM
7.00
-1.54 (-18.03%)
Pre-market: Nov 21, 2024, 5:28 AM EST
Viemed Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 214.3 | 183.01 | 138.83 | 117.06 | 131.31 | 80.26 | Upgrade
|
| Revenue Growth (YoY) | 26.22% | 31.82% | 18.60% | -10.85% | 63.61% | 24.50% | Upgrade
|
| Cost of Revenue | 85.13 | 70.23 | 54.15 | 43.65 | 51.2 | 24.25 | Upgrade
|
| Gross Profit | 129.18 | 112.78 | 84.68 | 73.41 | 80.11 | 56.01 | Upgrade
|
| Selling, General & Admin | 101.49 | 87.35 | 68.16 | 54.89 | 52.83 | 41.38 | Upgrade
|
| Research & Development | 2.92 | 2.78 | 2.7 | 2.11 | 1.08 | 0.85 | Upgrade
|
| Other Operating Expenses | -0.61 | -0.1 | -0.79 | -0.12 | -0.45 | 0 | Upgrade
|
| Operating Expenses | 111.66 | 97.27 | 76.28 | 62.88 | 59.16 | 46.79 | Upgrade
|
| Operating Income | 17.51 | 15.51 | 8.4 | 10.53 | 20.95 | 9.22 | Upgrade
|
| Interest Expense | -0.89 | -0.42 | -0.2 | -0.32 | -0.51 | -0.31 | Upgrade
|
| Earnings From Equity Investments | -0.91 | 0.49 | 0.94 | 1.24 | 0.09 | -0.11 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | - | 0.36 | Upgrade
|
| EBT Excluding Unusual Items | 15.72 | 15.57 | 9.14 | 11.45 | 20.54 | 9.16 | Upgrade
|
| Merger & Restructuring Charges | -0.4 | -0.54 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.53 | -0.65 | -0.35 | -0.45 | 2.33 | -0.36 | Upgrade
|
| Other Unusual Items | -0.9 | - | 0.2 | 1.5 | 3.5 | - | Upgrade
|
| Pretax Income | 14.94 | 14.39 | 8.99 | 12.5 | 26.36 | 8.8 | Upgrade
|
| Income Tax Expense | 4.48 | 4.15 | 2.77 | 3.38 | -5.17 | 0.27 | Upgrade
|
| Net Income | 10.43 | 10.24 | 6.22 | 9.13 | 31.53 | 8.53 | Upgrade
|
| Net Income to Common | 10.43 | 10.24 | 6.22 | 9.13 | 31.53 | 8.53 | Upgrade
|
| Net Income Growth | 13.28% | 64.63% | -31.82% | -71.06% | 269.85% | -10.34% | Upgrade
|
| Shares Outstanding (Basic) | 39 | 38 | 39 | 39 | 39 | 38 | Upgrade
|
| Shares Outstanding (Diluted) | 41 | 40 | 40 | 41 | 41 | 40 | Upgrade
|
| Shares Change (YoY) | 0.99% | 1.44% | -2.15% | 0.38% | 1.96% | 0.18% | Upgrade
|
| EPS (Basic) | 0.27 | 0.27 | 0.16 | 0.23 | 0.81 | 0.23 | Upgrade
|
| EPS (Diluted) | 0.25 | 0.25 | 0.16 | 0.22 | 0.78 | 0.21 | Upgrade
|
| EPS Growth | 4.13% | 56.25% | -27.27% | -71.80% | 271.43% | -12.50% | Upgrade
|
| Free Cash Flow | 3.51 | 19.12 | 4.85 | 2.75 | 22.07 | 5.7 | Upgrade
|
| Free Cash Flow Per Share | 0.09 | 0.47 | 0.12 | 0.07 | 0.54 | 0.14 | Upgrade
|
| Gross Margin | 60.28% | 61.63% | 60.99% | 62.71% | 61.01% | 69.78% | Upgrade
|
| Operating Margin | 8.17% | 8.48% | 6.05% | 8.99% | 15.96% | 11.48% | Upgrade
|
| Profit Margin | 4.87% | 5.60% | 4.48% | 7.80% | 24.01% | 10.62% | Upgrade
|
| Free Cash Flow Margin | 1.64% | 10.45% | 3.49% | 2.35% | 16.80% | 7.10% | Upgrade
|
| EBITDA | 42.43 | 37.38 | 24.03 | 21.84 | 30.54 | 15.62 | Upgrade
|
| EBITDA Margin | 19.80% | 20.42% | 17.31% | 18.66% | 23.25% | 19.46% | Upgrade
|
| D&A For EBITDA | 24.92 | 21.86 | 15.63 | 11.31 | 9.58 | 6.4 | Upgrade
|
| EBIT | 17.51 | 15.51 | 8.4 | 10.53 | 20.95 | 9.22 | Upgrade
|
| EBIT Margin | 8.17% | 8.48% | 6.05% | 8.99% | 15.96% | 11.48% | Upgrade
|
| Effective Tax Rate | 29.98% | 28.82% | 30.79% | 27.01% | - | 3.08% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.